Bad-BH3

General Information


DRACP ID  DRACP03060

Peptide Name   Bad-BH3

Sequence  LWAAQRYGRELRRMSDEFEGSFKGL

Sequence Length  25

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Induce apoptosis Bcl-xL inhibitors BH3 peptides and mimetics



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Bcl-xL

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03060

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C133H204N40O38S

Absent amino acids  CHINPTV

Common amino acids  R

Mass  343164

Pl  9.29

Basic residues  5

Acidic residues  4

Hydrophobic residues  8

Net charge  1

Boman Index  -7502

Hydrophobicity  -87.6

Aliphatic Index  54.8

Half Life 
  Mammalian: 1 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  291.25

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25451027

Title  Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL

Doi 10.1016/j.jmb.2014.09.030

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.